HSIC Henry Schein, Inc. - Common Stock
About Henry Schein, Inc. - Common Stock Company overview from Wikipedia
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's largest provider of health care solutions to office-based dental and medical practitioners.
Read more
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's largest provider of health care solutions to office-based dental and medical practitioners.
History
In 1932, Henry Schein, a graduate of Columbia University College of Pharmacy, borrowed $500 and opened a pharmacy in Queens, New York. The company expanded into dental supplies in the 1960s, and by the late 1980s, Henry Schein held approximately 10 percent of the dental-supply market. Marvin Schein, Henry Schein's son, took over management of daily operations in 1971.
In 1978, founder Henry Schein's son Jay Schein became CEO of the company. When Jay Schein died of cancer in 1989, Stanley Bergman took over as CEO. Bergman was born in South Africa and came to New York in 1976, where he became an accountant. In 1980, he joined Henry Schein and was promoted to CFO.
Henry Schein Inc. filed with the U.S. Securities and Exchange Commission in 1995 to sell 6.2 million shares in an initial public offering with William Blair & Company as the lead underwriter. The IPO raised $72.8 million and began trading on the Nasdaq. By 1996, the company was up to $1.4 billion in sales and $29 million in profit under Bergman's leadership. That year, the company made seventeen acquisitions.
In August 1997, Henry Schein Inc. agreed to buy Sullivan Dental Products Inc. for approximately $318 million. The purchase made the company the world's largest distributor of dental equipment and supplies. By that point, Henry Schein had made 16 acquisitions in 1997. Also in 1997, Henry Schein acquired New York-based medical-products distributor Micro BioMedics Inc as well as Dentrix Dental Systems.
Henry Schein announced the acquisition of demedis GmbH and Euro Dental Holding GmbH in June 2004. In November 2009, it was announced that Henry Schein Inc. and Butler Animal Health Supply would be launching joint venture Butler Schein Animal Health, the largest veterinary sales and distribution company in the United States. Butler Schein Animal Health was rebranded as Henry Schein Animal Health in 2013. Between 1989 and 2016, Henry Schein purchased approximately 200 companies. The company's chief executive officer, Stanley Bergman, was announced as Chief Executive Magazine's CEO of the Year in May 2017.
In 2018, the FTC accused Benco Dental, Patterson Companies, and Henry Schein of violating antitrust laws. In October 2019, the FTC's Chief Administrative Law Judge dismissed the claims against Henry Schein while finding that Benco and Patterson violated U.S. antitrust laws.
In February 2019, Henry Schein spun off the company's animal health business and merged it with Vets First Choice to form a new company. The new company is established as Covetrus.
Henry Schein Inc. was one of the six main defendants in lawsuits with state and local governments of the opioid epidemic in the United States. The company was dismissed as a defendant in October 2019 in the bellwether Summit County, Ohio litigation.
In July 2022, Henry Schein acquired Condor Dental, a dental distribution company.
In April 2023, Henry Schein acquired Biotech Dental, a provider of dental implants, clear aligners, and digital dental software, based in Salon-de-Provence, France.
In July 2023, Henry Schein acquired S.I.N Implant System, a major provider of dental implants in Brazil.
On October 14, 2023, Henry Schein reported a major hack into its core systems, which included investor information, and payroll data - amounting to 35 Terabytes of data being exfiltrated from the company. This resulted in its applications and e-commerce site being unavailable for several days.
In July 2025, Henry Schein announced that Stanley Bergman would be stepping down as CEO at the end of 2025, however he will continue to serve as chairman of the board. In January 2026 the company announced Bergman's successor as Frederick Lowery, Executive Vice President and President, Laboratory Products and BioProduction at Thermo Fisher Scientific.
In 2025, Henry Schein ranked 333rd by revenue on the Fortune 500 list and 34th within the healthcare sector.
Operations
Dental
In 1997, Henry Schein acquired Sullivan Dental Products and Dentrix Dental Systems, making it the world's largest distributor of dental equipment and supplies.
Dentrix Ascend, is a cloud-based dental practice management software platform developed by Henry Schein One for dental offices. The software is accessible through a web browser and includes tools of scheduling, billing, patient records, imaging, and practice management.
Henry Schein established the Henry Schein Dental Business Institute in March 2015 to teach owners and operators of dental practices the fundamentals of business. The first class to complete the program graduated in March 2016. Henry Schein also launched the Henry Schein Digital Dentistry Program at Temple University's Maurice H. Kornberg School of Dentistry in 2016.
In May 2016, Henry Schein's entity Dentrix presented the DEXIS software's ability to integrate X-rays into a patient's chart. Zahn Dental, Henry Schein's laboratory supply business, acquired Custom Automated Prosthetics in June 2016. The acquisition enabled Henry Schein to expand its prosthetic offerings.
In August 2019, Henry Schein acquired a majority equity stake in Cliniclands, a distributor serving dental practices throughout Sweden, Denmark, and Norway.
In May 2021, Henry Schein announced it acquired an 80% ownership position in Jarvis Analytics, a software company that develops comprehensive data analytics tools for dental practitioners.
In June 2021, Henry Schein acquired a 70% ownership position in eAssist Dental Solutions (eAssist), the developer of a virtual dental billing outsourcing service.
In August 2022, Henry Schein acquired Midway Dental Supply, a full-service dental distributor serving across the Midwestern United States.
In January 2023, Henry Schein announced its subsidiary, eAssist Dental Solutions (eAssist), acquired a majority interest in Unitas PPO Solutions (Unitas), a service provider that works with dental practices to assess their commercial insurance participation, set competitive fee-for-service rates, and negotiate contracted reimbursement with commercial insurers.
In July 2024, Henry Schein acquired abc dental AG, a full-service dental distributor offering consumables, equipment, and technical service to general practitioners, specialists, and dental laboratories in Switzerland.
Henry Schein One
In July 2018, Henry Schein and Internet Brands completed a joint venture to form Henry Schein One. The new company delivers integrated dental technology to help improve practice management and marketing as well as patient communication. Since the formation, Henry Schein One has included Dentrix, Dentrix Ascend, Dentalplans.com, Demandforce, Sesame Communications, and Officite as part of its portfolio of dental technology products.
In July 2019, Henry Schein One acquired Elite Computer Italia S.r.L. (Elite), a full-service software company that delivers practice management solutions to dental practices in Italy.
In November 2022, Henry Schein One announced a partnership with VideaHealth, a dental AI platform. As a result, Henry Schein One introduced Dentrix Detect AI, an AI-enabled X-Ray analysis tool. The integration with VideaHealth's FDA-cleared computer-assisted detection (CADe) device can help oral health professionals use AI in dental practices.
In December 2023, Henry Schein One was named to Utah Business Magazine's Best Companies to Work For list.
Medical
In November 2014, Henry Schein Medical announced a strategic arrangement with Cardinal Health. Cardinal Health's physician office-sales organization consolidated into Henry Schein Medical.
In March 2019, Henry Schein acquired North American Rescue (NAR), the leading provider of survivability and casualty-care medical products to the defense and public-safety markets.
In January 2021, Henry Schein acquired a majority ownership position in Prism Medical Products, LLC (PRISM), a nationwide provider of specialty home medical supplies with a core competency in advanced wound care products.
In October 2023, Henry Schein acquired Shield Healthcare, Inc., a supplier of homecare medical products delivered directly to patients in their homes.
In April 2024, Henry Schein acquired TriMed, a developer of orthopedic devices for lower extremities (foot and ankle) and upper extremities (hand and wrist).
In January 2025, Henry Schein acquired all of the assets of Acentus, a medical supplier specializing in Continuous Glucose Monitors (CGMs).
Former division
Animal health
Henry Schein has spun off this division in early 2019 produces software that is used in veterinary practices designed to improve communication and data management including the online cloud-based application, Rapport. In February 2016, Henry Schein released Axis-Q, a software application designed to ease the recording and access of veterinary medical records.
Philanthropy
In 1998, Henry Schein's Back to School program was launched; this program provides underserved children with school supplies and has helped over 65,000 students since its foundation.
Since 1999, Henry Schein has held its annual ‘Holiday Cheer for Children’ program, which donates clothing, toys, and gift cards to over 20,000 children and their families throughout the holiday season.
In 2015, the Alpha Omega International Dental Society and Henry Schein Cares partnered to create the Alpha Omega-Henry Schein Cares Holocaust Survivors Oral Health Program, which offers pro bono oral care to Holocaust survivors. Since its inception, the program has provided treatment to over 1,600 individuals in the United States and Canada.
Since 2018, Henry Schein has supported the Special Olympics, in particular its Healthy Athletes program, through essential health care donations.
In April 2023, Henry Schein launched its Practice Green initiative, which seeks to encourage healthcare professionals to transition towards sustainable practices.
Henry Schein has also served as the exclusive product sponsor for the American Dental Association’s Give Kids A Smile Program. Henry Schein has contributed $20 million in oral health care products and more than 40,000 dental kits.
In April 2025, the Science Based Targets initiative (SBTi) approved Henry Schein's near-term and long-term science-based emissions reduction targets, verifying its net-zero science-based target by 2050.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
HSIC Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
HSIC Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
HSIC Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 7 28.0%
- Buy 7 28.0%
- Hold 10 40.0%
- Sell 1 4.0%
- Strong Sell 0 0.0%
12-Month Price Target
16 analysts · 2026-08-19Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $1.27 | $1.26 | 0.01% |
| March 31, 2026 | $1.32 | $1.24 | 0.08% |
| Dec. 31, 2025 | $1.34 | $1.33 | 0.01% |
| Sept. 30, 2025 | $1.38 | $1.30 | 0.08% |
| June 30, 2025 | $1.10 | $1.22 | -0.12% |
| March 31, 2025 | $1.15 | $1.13 | 0.02% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| HSIC | $8.81B | 23.3 | 4.0% | 3.0% | 12.0% | 31.1% |
| MCK | $242.30B | 22.5 | 12.4% | 1.2% | -224.3% | 3.6% |
| COR | $60.61B | 39.3 | 9.3% | 0.48% | 144.3% | 3.6% |
| CAH | — | 32.9 | 14.2% | 0.67% | -60.5% | 3.8% |
| AHCO | $1.35B | -19.2 | -0.49% | -2.2% | -4.6% | — |
| ACH | — | — | — | — | — | — |
| MEDS | — | — | — | — | — | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 17
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | $8.88B | $11.57B | $10.63B | |
| Cost of Revenue | $9.08B | $8.66B | $8.48B | $8.82B | $8.73B | $7.30B | $6.89B | $6.51B | $6.14B | $8.35B | $7.62B | |
| Gross Profit | $4.11B | $4.02B | $3.86B | $3.83B | $3.67B | $2.82B | $3.09B | $2.91B | $2.75B | $3.23B | $3.01B | |
| SG&A Expense | $3.08B | $3.03B | $2.96B | $2.77B | $2.63B | $2.09B | $2.36B | $2.22B | $2.07B | $2.41B | $2.24B | |
| Operating Expenses | · | · | · | · | · | · | · | $2.70B | $2.53B | $2.41B | · | |
| Operating Income | $653M | $621M | $615M | $747M | $852M | $535M | $718M | $601M | $670M | $772M | $734M | |
| Interest Expense | $150M | $131M | $87M | $35M | $27M | $41M | $51M | $76M | $51M | $32M | $26M | |
| Interest Income | $33M | $24M | $17M | $8M | $6M | $10M | $16M | $15M | $12M | $13M | $13M | |
| Other Non-op | $-3M | $-1M | $-3M | $1M | $0 | $-4M | $-3M | $-3M | $-1M | $3M | $-141.0K | |
| Pretax Income | $533M | $513M | $542M | $721M | $831M | $500M | $680M | $537M | $630M | $756M | $721M | |
| Income Tax | $126M | $128M | $120M | $170M | $198M | $95M | $160M | $107M | $309M | $218M | $211M | |
| Net Income | $398M | $390M | $416M | $538M | $631M | $404M | $695M | $536M | $406M | $507M | $479M | |
| EPS (Basic) | $3.29 | $3.07 | $3.18 | $3.95 | $4.51 | $2.83 | $4.70 | $3.51 | $2.59 | $3.14 | $2.89 | |
| EPS (Diluted) | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 | $2.82 | $4.65 | $3.49 | $2.57 | $3.10 | $2.85 | |
| Shares (Basic) | 120,813,977 | 126,788,997 | 130,618,990 | 136,064,221 | 140,090,889 | 142,504,193 | 147,817,000 | 152,656,000 | 156,787,000 | 161,641,000 | 165,687,000 | |
| Shares (Diluted) | 121,717,876 | 127,779,228 | 131,748,171 | 137,755,670 | 141,772,781 | 143,403,682 | 149,257,000 | 153,707,000 | 158,208,000 | 163,723,000 | 168,250,000 | |
| EBITDA | $964M | $918M | $863M | $959M | $1.06B | $721M | $903M | $961M | · | $941M | $893M |
Balance Sheet 26
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $156M | $122M | $171M | $117M | $118M | $421M | · | $57M | $158M | $62M | $72M | |
| Receivables | $1.65B | $1.48B | $1.86B | $1.44B | $1.45B | $1.42B | $1.25B | $1.17B | $1.52B | $1.25B | $1.23B | |
| Inventory | $2.00B | $1.81B | $1.81B | $1.96B | $1.86B | $1.51B | $1.43B | $1.42B | $1.93B | $1.67B | $1.51B | |
| Prepaid Expense | $655M | $569M | $639M | $466M | $413M | $433M | $445M | $451M | $455M | $361M | $361M | |
| Current Assets | $4.46B | $3.98B | $4.49B | $3.99B | $3.84B | $3.79B | $3.23B | $4.18B | $4.09B | $3.34B | $3.23B | |
| PP&E (Net) | · | · | · | · | $366M | $342M | $330M | $314M | $375M | $334M | $318M | |
| PP&E (Gross) | $1.38B | $1.20B | $1.17B | $956M | $916M | $868M | $799M | $905M | $990M | $865M | $797M | |
| Accum. Depreciation | $759M | $670M | $672M | $573M | $550M | $526M | $469M | $591M | $615M | $531M | $478M | |
| Goodwill | $4.21B | $3.89B | $3.88B | $2.89B | $2.85B | $2.50B | $2.46B | $2.08B | $1.55B | $2.02B | $1.91B | |
| Intangibles | $1.02B | $1.02B | $916M | $587M | $668M | $479M | $573M | $376M | $670M | $621M | $593M | |
| Total Assets | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.86B | $6.81B | $6.53B | |
| Accounts Payable | $1.15B | $962M | $1.02B | $1.00B | $1.05B | $1.01B | $880M | $786M | $1.15B | $1.01B | $1.01B | |
| Short-term Debt | $764M | $650M | $264M | $103M | $51M | $73M | $24M | $951M | · | · | · | |
| Current Liabilities | $3.23B | $2.80B | $2.68B | $2.22B | $2.31B | $2.28B | $2.04B | $3.22B | $2.83B | $2.32B | $2.15B | |
| Capital Leases | $251M | $259M | $310M | $275M | $268M | $239M | $176M | $0 | · | · | · | |
| Deferred Tax | $146M | $102M | $54M | $36M | $42M | $30M | $65M | $27M | $50M | $52M | $253M | |
| Other Non-current Liabilities | $486M | $387M | $436M | $361M | $377M | $393M | $331M | $358M | $420M | $264M | $212M | |
| Total Liabilities | $6.42B | $5.38B | $5.42B | $3.94B | $3.81B | $3.46B | $3.23B | $4.65B | $4.21B | $3.35B | $3.08B | |
| Long-term Debt | · | · | · | $1.05B | $822M | · | · | · | · | · | · | |
| Total Debt | $764M | $650M | $264M | $103M | $51M | $73M | $24M | · | · | · | · | |
| Paid-in Capital | $177M | $0 | $0 | $0 | $0 | $0 | $48M | $0 | · | · | · | |
| Retained Earnings | $3.29B | $3.77B | $3.86B | $3.68B | $3.60B | $3.45B | $3.12B | $3.21B | $2.94B | $2.98B | $2.90B | |
| AOCI | $-226M | $-379M | $-206M | $-233M | $-171M | $-108M | $-167M | $-249M | $-130M | $-317M | $-220M | |
| Stockholders' Equity | $3.25B | $3.39B | $3.65B | $3.45B | $3.42B | $3.35B | $3.00B | $2.96B | $2.81B | $2.79B | $2.88B | |
| Liabilities + Equity | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.86B | $6.76B | $6.50B | |
| Shares Outstanding | 115,771,149 | 124,155,884 | 129,247,765 | 131,792,817 | 137,145,558 | 142,462,571 | 143,353,459 | 151,401,668 | 153,690,146 | 158,805,010 | 164,830,640 |
Cash Flow 19
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $311M | $297M | $248M | $212M | $210M | $186M | $185M | $144M | $134M | $170M | $159M | |
| Stock-based Comp | $39M | $39M | $39M | $54M | $78M | $9M | $45M | $33M | $37M | $58M | $45M | |
| Deferred Tax | $5M | $-61M | $-20M | $-73M | $-11M | $-53M | $-4M | $-25M | $1M | $-37M | $-6M | |
| Amort. of Intangibles | $180M | $185M | $152M | $126M | $124M | $106M | $108M | $75M | $70M | $98M | $93M | |
| Restructuring | $105M | $110M | $80M | $128M | $8M | · | · | $54M | $0 | $46M | $35M | |
| Other Non-cash | $-41M | $183M | $-183M | $-129M | $-199M | $54M | $-266M | $-54M | · | $-82M | $-90M | |
| Operating Cash Flow | $712M | $848M | $500M | $602M | $710M | $599M | $654M | $685M | $546M | $643M | $616M | |
| CapEx | $139M | $148M | $147M | $96M | $79M | $49M | $76M | $71M | $62M | $70M | $72M | |
| Investing Cash Flow | $-400M | $-430M | $-1.14B | $-276M | $-677M | $-115M | $-424M | $-193M | $-342M | $-316M | $-260M | |
| Debt Issued | $489M | $120M | $1.37B | $270M | $305M | $501M | $741.0K | $115M | $200M | $261M | $135M | |
| Net Debt Issued | $445M | $-198M | $900M | $211M | $183M | $-110M | $-260M | $87M | · | $245M | $-66M | |
| Stock Issued | $250M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $850M | $385M | $250M | $485M | $401M | $74M | $525M | $200M | $450M | $550M | $300M | |
| Net Stock Activity | $-600M | $-385M | $-250M | $-485M | $-401M | $-74M | $-525M | $-200M | · | $-550M | $-300M | |
| Financing Cash Flow | $-188M | $-510M | $701M | $-315M | $-333M | $-187M | $-216M | $-604M | $-113M | $-327M | $-348M | |
| Net Change in Cash | $34M | $-49M | $54M | $-1M | $-303M | $315M | $26M | $-94M | $225M | $-10M | $-17M | |
| Taxes Paid | $128M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $573M | $700M | $353M | $506M | $631M | $550M | $578M | $594M | · | $545M | $515M | |
| Levered FCF | $458M | $602M | $285M | $472M | $610M | $517M | $539M | $533M | · | $523M | $497M |
Profitability 8
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% | 27.8% | 30.9% | 27.2% | · | 28.0% | 28.3% | |
| Operating Margin | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% | 5.3% | 7.2% | 5.7% | · | 6.7% | 6.9% | |
| Net Margin | 3.0% | 3.1% | 3.4% | 4.2% | 5.1% | 4.0% | 7.0% | 4.1% | · | 4.4% | 4.5% | |
| Pretax Margin | 4.0% | 4.0% | 4.4% | 5.7% | 6.7% | 4.9% | 6.8% | 5.3% | · | 6.5% | 6.8% | |
| EBITDA Margin | 7.3% | 7.2% | 7.0% | 7.6% | 8.6% | 7.1% | 9.0% | 7.3% | · | 8.1% | 8.4% | |
| ROA | 3.7% | 3.8% | 4.3% | 6.3% | 7.8% | 5.4% | 8.9% | 6.6% | · | 7.6% | 7.6% | |
| ROE | 12.0% | 11.1% | 11.7% | 15.7% | 18.6% | 12.7% | 23.3% | 18.6% | · | 17.8% | 16.8% | |
| ROIC | 12.4% | 11.5% | 12.2% | 16.1% | 18.7% | 12.7% | 18.2% | 19.7% | · | 19.7% | 18.0% |
Liquidity & Solvency 4
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | 1.7 | 1.8 | 1.7 | 1.7 | 1.6 | 1.3 | · | 1.4 | 1.5 | |
| Quick Ratio | 0.6 | 0.6 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | 0.5 | · | 0.6 | 0.6 | |
| Debt / Equity | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | · | · | |
| Interest Coverage | 4.4 | 4.7 | 7.1 | 17.0 | 30.9 | 12.9 | 14.1 | 9.6 | · | 24.2 | 28.2 |
Efficiency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.2 | 1.3 | 1.5 | 1.5 | 1.4 | 1.3 | 1.6 | · | 1.7 | 1.7 | |
| Inventory Turnover | 4.8 | 4.8 | 4.5 | 4.6 | 5.2 | 5.0 | 4.8 | 4.9 | · | 5.3 | 5.4 | |
| Receivables Turnover | 8.4 | 7.6 | 7.5 | 8.7 | 8.6 | 7.6 | 8.3 | 8.4 | · | 9.3 | 9.0 |
Growth Rates 9
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.0% | 2.7% | -2.4% | 2.0% | 22.6% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1.4% | 0.73% | 6.8% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 7.2% | -3.5% | -19.2% | -12.1% | 57.8% | · | · | · | · | · | · | |
| EPS CAGR 3Y | -5.8% | -11.8% | 3.9% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 3.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 2.1% | -6.2% | -22.7% | -14.7% | 56.2% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -9.6% | -14.8% | 0.98% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.30% | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM) 14
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | · | $11.57B | $10.63B | |
| Net Income TTM | $398M | $390M | $416M | $538M | $631M | $404M | $695M | $536M | · | $507M | $479M | |
| Market Cap | $8.81B | $8.74B | $9.79B | $10.53B | $10.28B | $9.38B | $9.54B | $9.25B | · | $4.72B | $5.08B | |
| Enterprise Value | $9.42B | $9.27B | $9.88B | $10.51B | $10.21B | · | · | · | · | · | · | |
| P/E | 23.3 | 23.1 | 24.0 | 20.4 | 16.8 | 23.3 | 14.3 | 17.5 | · | 19.2 | 21.6 | |
| P/S | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | 0.9 | 1.0 | 1.0 | · | 0.4 | 0.5 | |
| P/B | 2.7 | 2.6 | 2.7 | 3.1 | 3.0 | 2.8 | 3.2 | 3.1 | · | 1.7 | 1.8 | |
| P / Tangible Book | · | · | · | · | · | 25.7 | · | · | · | · | · | |
| P / Cash Flow | 12.4 | 10.3 | 19.6 | 17.5 | 14.5 | 15.7 | 14.6 | 13.5 | · | 7.7 | 8.7 | |
| P / FCF | 15.4 | 12.5 | 27.7 | 20.8 | 16.3 | 17.0 | 16.5 | 15.6 | · | 8.7 | 9.9 | |
| EV / EBITDA | 9.8 | 10.1 | 11.4 | 11.0 | 9.6 | · | · | · | · | · | · | |
| EV / FCF | 16.4 | 13.2 | 28.0 | 20.8 | 16.2 | · | · | · | · | · | · | |
| EV / Revenue | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | · | · | · | · | · | · | |
| Earnings Yield | 4.3% | 4.3% | 4.2% | 4.9% | 5.9% | 4.3% | 7.0% | 5.7% | · | 5.2% | 4.6% |
Income Statement 16
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.46B | $3.37B | $3.44B | $3.34B | $3.24B | $3.17B | $3.19B | $3.17B | $3.14B | $3.17B | $3.02B | $3.16B | $3.06B | $3.37B | $3.07B | |
| Cost of Revenue | $2.36B | $2.30B | $2.37B | $2.31B | $2.22B | $2.17B | $2.20B | $2.18B | $2.12B | $2.16B | $2.09B | $2.17B | $2.09B | $2.37B | $2.15B | |
| Gross Profit | $1.10B | $1.07B | $1.06B | $1.03B | $1.02B | $1.00B | $993M | $993M | $1.02B | $1.01B | $924M | $995M | $966M | $999M | $914M | |
| SG&A Expense | $831M | $809M | $808M | $760M | $778M | $738M | $738M | $724M | $781M | $791M | $807M | $725M | $717M | $761M | $648M | |
| Operating Income | $171M | $182M | $163M | $164M | $151M | $175M | $155M | $157M | $159M | $150M | $39M | $200M | $175M | $72M | $211M | |
| Interest Expense | $43M | $39M | $39M | $38M | $38M | $35M | $35M | $34M | $32M | $30M | $29M | $25M | $14M | $12M | $8M | |
| Interest Income | $8M | $7M | $9M | $9M | $9M | $6M | $6M | $7M | $6M | $5M | $5M | $6M | $3M | $3M | $1M | |
| Other Non-op | $1M | $0 | $0 | $-1M | $-1M | $-1M | $0 | $-2M | $-1M | $2M | $-1M | $-2M | $-1M | $0 | $1M | |
| Pretax Income | $137M | $150M | $133M | $134M | $121M | $145M | $126M | $128M | $132M | $127M | $14M | $179M | $163M | $63M | $205M | |
| Income Tax | $34M | $38M | $32M | $28M | $31M | $35M | $31M | $32M | $33M | $32M | $1M | $39M | $39M | $15M | $46M | |
| Net Income | $94M | $107M | $101M | $101M | $86M | $110M | $94M | $99M | $104M | $93M | $18M | $137M | $121M | $47M | $150M | |
| EPS (Basic) | $0.83 | $0.93 | $0.85 | $0.84 | $0.71 | $0.89 | $0.75 | $0.79 | $0.81 | $0.72 | $0.14 | $1.06 | $0.92 | $0.37 | $1.10 | |
| EPS (Diluted) | $0.82 | $0.92 | $0.85 | $0.84 | $0.70 | $0.88 | $0.75 | $0.78 | $0.80 | $0.72 | $0.14 | $1.05 | $0.91 | $0.36 | $1.09 | |
| Shares (Basic) | 113,451,329 | 114,939,640 | -245,089,515 | 120,199,552 | 121,927,867 | 123,776,073 | -255,840,759 | 126,124,715 | 127,784,380 | 128,720,661 | -269,727 | 130,388,353 | 131,365,789 | -274,191,526 | 135,608,678 | |
| Shares (Diluted) | 114,390,366 | 116,061,244 | -246,803,540 | 121,036,247 | 122,636,948 | 124,848,221 | -257,691,792 | 127,054,934 | 128,646,506 | 129,769,580 | -401,001 | 131,442,135 | 133,039,886 | -277,434,915 | 137,084,049 | |
| EBITDA | $255M | $263M | · | $244M | $151M | $248M | · | $157M | $159M | $223M | · | $200M | $227M | · | $211M |
Balance Sheet 24
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $157M | $138M | $156M | $136M | $145M | $127M | $122M | $126M | $138M | $159M | · | $166M | $126M | · | · | |
| Receivables | $1.76B | $1.72B | $1.65B | $1.74B | $1.65B | $1.58B | $1.48B | $1.66B | $1.56B | $1.64B | $1.86B | $1.57B | $1.47B | $1.44B | $1.51B | |
| Inventory | $2.06B | $2.01B | $2.00B | $1.91B | $1.91B | $1.84B | $1.81B | $1.75B | $1.66B | $1.69B | · | $1.83B | $1.92B | · | $1.82B | |
| Prepaid Expense | $621M | $625M | $655M | $604M | $545M | $490M | $569M | $607M | $587M | $589M | · | $541M | $438M | · | $509M | |
| Current Assets | $4.60B | $4.50B | $4.46B | $4.39B | $4.24B | $4.04B | $3.98B | $4.15B | $3.94B | $4.08B | · | $4.11B | $3.95B | · | $3.96B | |
| PP&E (Gross) | · | · | $1.38B | · | · | · | $1.20B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $759M | · | · | · | $670M | · | · | · | · | · | · | · | · | |
| Goodwill | $4.27B | $4.28B | $4.21B | $4.15B | $4.08B | $3.96B | $3.89B | $3.99B | $3.90B | $3.83B | $3.88B | $3.60B | $2.92B | $2.89B | $2.87B | |
| Intangibles | $965M | $1.01B | $1.02B | $1.05B | $1.04B | $1.03B | $1.02B | $1.10B | $1.08B | $915M | · | $834M | $548M | · | $635M | |
| Total Assets | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | · | $9.81B | $8.57B | · | $8.53B | |
| Accounts Payable | $1.14B | $1.04B | $1.15B | $1.03B | $918M | $908M | $962M | $1.03B | $867M | $879M | · | $953M | $855M | · | $957M | |
| Short-term Debt | $1.02B | $1.05B | $764M | $913M | $901M | $867M | $650M | $638M | $505M | $264M | · | $12M | $236M | · | $107M | |
| Current Liabilities | $3.49B | $3.30B | $3.23B | $3.15B | $3.01B | $2.92B | $2.80B | $2.93B | $2.55B | $2.33B | · | $2.09B | $2.17B | · | $2.15B | |
| Capital Leases | $275M | $263M | $251M | $264M | $259M | $256M | $259M | $262M | $261M | $266M | · | $314M | $274M | · | $271M | |
| Deferred Tax | $153M | $158M | $146M | $144M | $147M | $135M | $102M | $123M | $115M | $77M | · | $91M | $40M | · | $37M | |
| Other Non-current Liabilities | $442M | $437M | $486M | $487M | $504M | $485M | $387M | $414M | $431M | $423M | · | $396M | $368M | · | $338M | |
| Total Liabilities | $6.66B | $6.48B | $6.42B | $6.20B | $6.01B | $5.76B | $5.38B | $5.63B | $5.25B | $5.11B | · | $4.71B | $3.88B | · | $3.73B | |
| Total Debt | $1.02B | $1.05B | · | $913M | $901M | $867M | · | $638M | $505M | $264M | · | $12M | · | · | $107M | |
| Paid-in Capital | $140M | $167M | $177M | $207M | $186M | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | · | $0 | |
| Retained Earnings | $3.20B | $3.29B | $3.29B | $3.38B | $3.48B | $3.63B | $3.77B | $3.77B | $3.80B | $3.84B | · | $3.90B | $3.68B | · | $3.92B | |
| AOCI | $-184M | $-189M | $-226M | $-222M | $-227M | $-317M | $-379M | $-264M | $-292M | $-239M | $-206M | $-247M | $-213M | $-233M | $-312M | |
| Stockholders' Equity | $3.16B | $3.27B | $3.25B | $3.36B | $3.44B | $3.31B | $3.39B | $3.50B | $3.51B | $3.60B | · | $3.65B | $3.47B | · | $3.61B | |
| Liabilities + Equity | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | · | $9.81B | $8.57B | · | $8.53B | |
| Shares Outstanding | 111,916,222 | 114,424,682 | 115,771,149 | 118,567,917 | 121,895,045 | 122,243,683 | 124,155,884 | 125,154,194 | 127,080,545 | 128,480,909 | 129,247,765 | 129,935,883 | 131,196,783 | 131,792,817 | 135,258,887 |
Cash Flow 17
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $84M | $81M | $82M | $80M | $76M | $73M | $76M | $74M | $74M | $73M | $68M | $69M | $52M | $52M | $52M | |
| Stock-based Comp | $13M | $3M | $10M | $13M | $11M | $5M | $9M | $10M | $12M | $8M | $1M | $14M | $10M | $10M | $17M | |
| Deferred Tax | $-10M | $2M | $5M | $7M | $0 | $-7M | $-20M | $-22M | $-21M | $2M | $-16M | $-1M | $2M | $-53M | $-5M | |
| Restructuring | $29M | $12M | $23M | $34M | $23M | $25M | $37M | $48M | $15M | $10M | · | $11M | $30M | · | $9M | |
| Other Non-cash | · | $-290M | · | · | · | $-144M | · | · | · | $21M | · | · | $-158M | · | · | |
| Operating Cash Flow | $242M | $-97M | $381M | $174M | $120M | $37M | $204M | $151M | $296M | $197M | $-32M | $231M | $27M | $254M | $98M | |
| CapEx | $30M | $25M | $43M | $33M | $32M | $31M | $36M | $34M | $37M | $41M | $39M | $40M | $31M | $29M | $24M | |
| Investing Cash Flow | $-65M | $-63M | $-147M | $-56M | $-98M | $-99M | $-58M | $-91M | $-209M | $-72M | $-327M | $-468M | $-39M | $-65M | $-152M | |
| Debt Issued | $87M | $57M | $175M | $70M | $94M | $150M | $0 | $30M | $0 | $90M | $210M | $750M | $31M | $105M | $165M | |
| Net Debt Issued | · | $18M | · | · | · | $135M | · | · | · | $30M | · | · | $30M | · | · | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Stock Repurchased | $200M | $125M | $200M | $203M | $286M | $161M | $75M | $135M | $100M | $75M | $50M | $50M | $100M | $285M | $90M | |
| Net Stock Activity | · | $-125M | · | · | · | $-161M | · | · | · | $-75M | · | · | $-100M | · | · | |
| Financing Cash Flow | $-168M | $120M | $-206M | $-127M | $56M | $89M | $-204M | $-41M | $-114M | $-151M | $394M | $248M | $21M | $-194M | $74M | |
| Net Change in Cash | $19M | $-18M | $20M | $-9M | $18M | $5M | $-4M | $-12M | $-21M | $-12M | $5M | $29M | $9M | $-6M | $15M | |
| Free Cash Flow | · | $-122M | · | · | · | $6M | · | · | · | $156M | · | · | $-4M | · | · | |
| Levered FCF | · | $-151M | · | · | · | $-21M | · | · | · | $134M | · | · | $-15M | · | · |
Profitability 8
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.8% | 31.8% | · | 30.7% | 31.4% | 31.6% | · | 31.3% | 32.5% | 31.9% | · | 31.5% | 31.6% | · | 29.8% | |
| Operating Margin | 5.0% | 5.4% | · | 4.9% | 4.7% | 5.5% | · | 5.0% | 5.1% | 4.7% | · | 6.3% | 5.7% | · | 6.9% | |
| Net Margin | 2.7% | 3.2% | · | 3.0% | 2.6% | 3.5% | · | 3.1% | 3.3% | 2.9% | · | 4.3% | 4.0% | · | 4.9% | |
| Pretax Margin | 4.0% | 4.5% | · | 4.0% | 3.7% | 4.6% | · | 4.0% | 4.2% | 4.0% | · | 5.7% | 5.3% | · | 6.7% | |
| EBITDA Margin | 7.4% | 7.8% | · | 7.3% | 4.7% | 7.8% | · | 5.0% | 5.1% | 7.0% | · | 6.3% | 7.4% | · | 6.9% | |
| ROA | 0.84% | 0.98% | · | 0.93% | 0.81% | 1.1% | · | 0.97% | 1.1% | 0.99% | · | 1.5% | · | · | 1.8% | |
| ROE | 2.9% | 3.2% | · | 2.9% | 2.5% | 3.2% | · | 2.8% | 2.9% | 2.6% | · | 3.8% | · | · | 4.2% | |
| ROIC | 3.1% | 3.1% | · | 3.0% | 2.6% | 3.2% | · | 2.8% | 3.0% | 2.9% | · | 4.3% | · | · | 4.4% |
Liquidity & Solvency 4
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.7 | · | 2.0 | · | · | 1.8 | |
| Quick Ratio | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.7 | 0.8 | · | 0.8 | · | · | 0.7 | |
| Debt / Equity | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.1 | 0.1 | · | 0.0 | · | · | 0.0 | |
| Interest Coverage | 4.0 | 4.7 | · | 4.3 | 4.0 | 5.0 | · | 4.6 | 5.0 | 5.0 | · | 8.0 | 12.5 | · | 19.2 |
Efficiency 3
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | · | · | 0.4 | |
| Inventory Turnover | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | · | · | 1.2 | |
| Receivables Turnover | 2.0 | 2.0 | · | 2.0 | 2.0 | 2.0 | · | 2.0 | 2.1 | 2.0 | · | 2.1 | · | · | 2.0 |
Valuation (TTM) 14
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.40B | $13.12B | · | $12.92B | $12.72B | $12.65B | · | $12.64B | $12.57B | $12.49B | · | $12.39B | $12.34B | · | $12.45B | |
| Net Income TTM | $388M | $404M | · | $396M | $399M | $406M | · | $433M | $474M | $491M | · | $548M | $612M | · | $653M | |
| Market Cap | $9.51B | $8.25B | · | $7.83B | $8.93B | $8.39B | · | $9.16B | $8.15B | $9.70B | · | $9.65B | · | · | $9.11B | |
| Enterprise Value | $10.37B | $9.16B | · | $8.61B | $9.69B | $9.13B | · | $9.68B | $8.51B | $9.81B | · | $9.49B | · | · | · | |
| P/E | 25.9 | 21.6 | · | 20.6 | 23.2 | 21.6 | · | 21.9 | 17.7 | 20.2 | · | 18.1 | 18.3 | · | 14.3 | |
| P/S | 0.7 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.8 | · | 0.8 | · | · | 0.7 | |
| P/B | 3.0 | 2.5 | · | 2.3 | 2.6 | 2.5 | · | 2.6 | 2.3 | 2.7 | · | 2.6 | · | · | 2.5 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 85.9 | |
| P / Cash Flow | · | -85.1 | · | · | · | 226.7 | · | · | · | 49.3 | · | · | · | · | · | |
| P / FCF | · | -67.6 | · | · | · | 1398.1 | · | · | · | 62.2 | · | · | · | · | · | |
| EV / EBITDA | 40.7 | 34.8 | · | 35.3 | 64.2 | 36.8 | · | 61.6 | 53.5 | 44.0 | · | 47.5 | · | · | · | |
| EV / FCF | · | -75.1 | · | · | · | 1521.4 | · | · | · | 62.9 | · | · | · | · | · | |
| EV / Revenue | 0.8 | 0.7 | · | 0.7 | 0.8 | 0.7 | · | 0.8 | 0.7 | 0.8 | · | 0.8 | · | · | · | |
| Earnings Yield | 3.9% | 4.6% | · | 4.8% | 4.3% | 4.6% | · | 4.6% | 5.7% | 5.0% | · | 5.5% | 5.5% | · | 7.0% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| Revenue | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B |
| Gross Margin % | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% |
| Operating Margin % | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% |
| Net Income | $398M | $390M | $416M | $538M | $631M |
| Diluted EPS | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 |
Balance Sheet
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| Debt / Equity | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 |
| Current Ratio | 1.4 | 1.4 | 1.7 | 1.8 | 1.7 |
| Quick Ratio | 0.6 | 0.6 | 0.8 | 0.7 | 0.7 |
Cash Flow
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| Free Cash Flow | $573M | $700M | $353M | $506M | $631M |
Latest News Recent headlines mentioning this company
Trading Signals Recent buy/sell signals with entry price and risk/reward ratio
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 604 filers · $7.6B total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 68 (-4 vs prior Q) | 60 (+14 vs prior Q) | 172 (-5 vs prior Q) | 203 (+21 vs prior Q) | +14.5M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | $1,307,257,713 | 15,652,032 | 17.12% | Shares |
| Artisan Partners Limited Partnership | $540,162,844 | 6,467,467 | 7.07% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $530,073,795 | 6,346,669 | 6.94% | Shares |
| STATE STREET CORP | $359,576,652 | 4,305,276 | 4.71% | Shares |
| FMR LLC | $349,717,366 | 4,187,229 | 4.58% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $345,225,076 | 4,133,442 | 4.52% | Shares |
| AMERICAN CENTURY COMPANIES INC | $288,743,396 | 3,457,175 | 3.78% | Shares |
| Southpoint Capital Advisors LP | $275,616,000 | 3,300,000 | 3.61% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $256,689,867 | 3,073,394 | 3.36% | Shares |
| CITADEL ADVISORS LLC | $243,970,272 | 2,921,100 | 3.19% | Shares |
| Palestra Capital Management LLC | $204,347,632 | 2,446,691 | 2.68% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $200,544,294 | 2,405,837 | 2.63% | Shares |
| FIDUCIARY MANAGEMENT INC /WI/ | $151,785,323 | 1,817,353 | 1.99% | Shares |
| Burgundy Asset Management Ltd. | $151,049,204 | 2,170,871 | 1.98% | Shares |
| LYRICAL ASSET MANAGEMENT LP | $122,553,156 | 1,467,351 | 1.60% | Shares |
| Swedbank AB | $109,479,854 | 1,310,822 | 1.43% | Shares |
| M.D. Sass, LLC | $107,485,396 | 1,286,942 | 1.41% | Shares |
| SNYDER CAPITAL MANAGEMENT L P | $107,341,992 | 1,285,225 | 1.41% | Shares |
| NORGES BANK | $103,383,729 | 1,237,832 | 1.35% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $86,592,951 | 1,036,793 | 1.13% | Shares |
| NOMURA HOLDINGS INC | $77,065,658 | 922,721 | 1.01% | Shares |
| PZENA INVESTMENT MANAGEMENT LLC | $71,888,420 | 860,733 | 0.94% | Shares |
| Ananym Capital Management, LP | $57,978,164 | 694,183 | 0.76% | Shares |
| Ulysses Management LLC | $55,570,700 | 665,358 | 0.73% | Shares |
| STALEY CAPITAL ADVISERS INC | $55,252,489 | 661,548 | 0.72% | Shares |
| DME Capital Management, LP | $52,173,274 | 624,680 | 0.68% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $45,489,502 | 544,654 | 0.60% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $35,970,895 | 430,686 | 0.47% | Shares |
| GOLDMAN SACHS GROUP INC | $35,392,853 | 423,765 | 0.46% | Shares |
| Clarkston Capital Partners, LLC | $35,168,100 | 421,074 | 0.46% | Shares |
| LONE PEAK GLOBAL INVESTORS LLC | $33,404,158 | 399,954 | 0.44% | Shares |
| GAMCO INVESTORS, INC. ET AL | $30,537,668 | 365,633 | 0.40% | Shares |
| PRIVATE MANAGEMENT GROUP INC | $27,285,483 | 326,694 | 0.36% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $25,194,142 | 301,654 | 0.33% | Shares |
| BlackRock, Inc. | $24,670,305 | 295,382 | 0.32% | Shares |
| GABELLI FUNDS LLC | $24,182,047 | 289,536 | 0.32% | Shares |
| Zuckerman Investment Group, LLC | $24,062,613 | 288,106 | 0.32% | Shares |
| JANE STREET GROUP, LLC | $22,976,352 | 275,100 | 0.30% | Call option |
| Petrus Trust Company, LTA | $22,550,400 | 270,000 | 0.30% | Shares |
| P2 Capital Partners, LLC | $22,089,871 | 264,486 | 0.29% | Shares |
| BANK OF AMERICA CORP /DE/ | $21,414,277 | 256,397 | 0.28% | Shares |
| VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | $21,151,189 | 253,247 | 0.28% | Shares |
| RHUMBLINE ADVISERS | $21,008,017 | 251,534 | 0.28% | Shares |
| UBS Group AG | $20,880,000 | 250,000 | 0.27% | Put option |
| LAZARD ASSET MANAGEMENT LLC | $20,493,720 | 245,375 | 0.27% | Shares |
| Cresset Asset Management, LLC | $20,165,236 | 241,442 | 0.26% | Shares |
| Balyasny Asset Management L.P. | $19,401,863 | 232,302 | 0.25% | Shares |
| Quantinno Capital Management LP | $18,131,858 | 217,096 | 0.24% | Shares |
| Vanguard Global Advisers, LLC | $17,149,245 | 205,331 | 0.22% | Shares |
| FIRST TRUST ADVISORS LP | $16,585,245 | 198,579 | 0.22% | Shares |
| EVERETT HARRIS & CO /CA/ | $16,551,743 | 198,177 | 0.22% | Shares |
| California Public Employees Retirement System | $16,351,212 | 195,776 | 0.21% | Shares |
| Swiss National Bank | $16,344,864 | 195,700 | 0.21% | Shares |
| Leith Wheeler Investment Counsel Ltd. | $15,975,960 | 191,283 | 0.21% | Shares |
| WESTWOOD HOLDINGS GROUP INC | $15,708,859 | 188,085 | 0.21% | Shares |
| Woodline Partners LP | $15,637,951 | 187,236 | 0.20% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $14,874,912 | 178,100 | 0.19% | Call option |
| Amundi | $14,369,366 | 172,047 | 0.19% | Shares |
| Stephens Investment Management Group LLC | $14,100,765 | 168,831 | 0.18% | Shares |
| NUANCE INVESTMENTS, LLC | $14,045,116 | 168,165 | 0.18% | Shares |
| JANE STREET GROUP, LLC | $13,541,515 | 162,135 | 0.18% | Shares |
| BARCLAYS PLC | $12,852,476 | 153,885 | 0.17% | Shares |
| James J. Burns & Company, LLC | $12,843,455 | 153,777 | 0.17% | Shares |
| Ulysses Management LLC | $12,528,000 | 150,000 | 0.16% | Call option |
| Marathon Asset Management Ltd | $11,609,195 | 139,002 | 0.15% | Shares |
| CLARK ESTATES INC/NY | $11,275,200 | 135,000 | 0.15% | Shares |
| PFM Health Sciences, LP | $11,227,009 | 134,423 | 0.15% | Shares |
| Holocene Advisors, LP | $10,191,528 | 122,025 | 0.13% | Shares |
| Mitsubishi UFJ Asset Management Co., Ltd. | $10,070,173 | 120,572 | 0.13% | Shares |
| HEARTLAND ADVISORS INC | $10,022,400 | 120,000 | 0.13% | Shares |
| BANK OF NOVA SCOTIA | $9,519,692 | 113,981 | 0.12% | Shares |
| VICTORY CAPITAL MANAGEMENT INC | $9,502,822 | 113,779 | 0.12% | Shares |
| HFR Wealth Management, LLC | $9,454,965 | 113,206 | 0.12% | Shares |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $9,138,210 | 123,992 | 0.12% | Shares |
| Illinois Municipal Retirement Fund | $8,914,173 | 106,731 | 0.12% | Shares |
| STATE OF WISCONSIN INVESTMENT BOARD | $8,898,137 | 106,539 | 0.12% | Shares |
| Clearline Capital LP | $8,696,854 | 104,129 | 0.11% | Shares |
| Stenger Family Office, LLC | $8,511,793 | 24,721 | 0.11% | Shares |
| FIRST MANHATTAN CO. LLC. | $8,509,769 | 101,889 | 0.11% | Shares |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $8,184,793 | 97,998 | 0.11% | Shares |
| LAKEWOOD CAPITAL MANAGEMENT, LP | $8,101,440 | 97,000 | 0.11% | Shares |
| Man Group plc | $7,975,325 | 95,490 | 0.10% | Shares |
| VANGUARD ASSET MANAGEMENT, Ltd | $7,705,472 | 92,259 | 0.10% | Shares |
| BANYAN CAPITAL MANAGEMENT, INC. | $7,621,951 | 91,259 | 0.10% | Shares |
| ENVESTNET ASSET MANAGEMENT INC | $7,521,178 | 90,052 | 0.10% | Shares |
| NEUBERGER BERMAN GROUP LLC | $6,802,084 | 81,443 | 0.09% | Shares |
| ALLIANCEBERNSTEIN L.P. | $6,719,450 | 91,173 | 0.09% | Shares |
| FRANKLIN RESOURCES INC | $6,613,615 | 79,186 | 0.09% | Shares |
| Berger Financial Group, Inc | $6,535,023 | 78,245 | 0.09% | Shares |
| WINTON GROUP Ltd | $6,439,392 | 77,100 | 0.08% | Shares |
| RIVER GLOBAL INVESTORS LLP | $6,404,253 | 92,547 | 0.08% | Shares |
| Brandywine Global Investment Management, LLC | $6,305,262 | 83,425 | 0.08% | Shares |
| Foyston, Gordon & Payne Inc | $6,304,173 | 75,481 | 0.08% | Shares |
| Allianz Asset Management GmbH | $6,210,714 | 74,362 | 0.08% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $6,145,736 | 73,584 | 0.08% | Shares |
| AdvisorShares Investments LLC | $5,879,892 | 70,401 | 0.08% | Shares |
| PNC Financial Services Group, Inc. | $5,687,294 | 68,095 | 0.07% | Shares |
| Squarepoint Ops LLC | $5,369,083 | 64,285 | 0.07% | Shares |
| Cinctive Capital Management LP | $5,110,088 | 61,184 | 0.07% | Shares |
| RAYMOND JAMES FINANCIAL INC | $4,965,598 | 59,454 | 0.07% | Shares |
Company insiders 51 insiders · 23 officers · 21 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Andrea Albertini | CEO, Global Dist. & Tech. | Dec. 10, 2025 F | 65,900 | 0 | 0 | $0 |
| Bradford C Connett | CEO, NA Distribution Group | March 19, 2025 S | 62,688 | 0 | 0 | $0 |
| Thomas C Popeck | CEO, Henry Schein Products | March 14, 2025 D | 36,257 | 0 | 0 | $0 |
| David B Brous Jr | CEO, Strategic Business Group | June 12, 2023 S | 68,690 | 0 | 0 | $0 |
| Karen Prange | EVP&CEO Gl.AH.Med.Den.Sur.Grp | March 2, 2018 A | 62,902 | 0 | 0 | $0 |
| Lonnie Shoff | CEO, Global Strat Port Grp | March 15, 2016 S | 31,000 | 0 | 0 | $0 |
| Ronald N. South | SVP & Chief Financial Officer | March 14, 2025 D | 81,374 | 0 | 0 | $0 |
| James P Breslawski | President | March 14, 2025 D | 200,227 | 0 | 0 | $0 |
| Bridget A Ross | President, Global Medical Grp | March 6, 2017 A | 9,654 | 0 | 0 | $0 |
| Michael Zack | President of Int'l Group | March 7, 2013 M | 48,716 | 0 | 0 | $0 |
| Michael S Ettinger | EVP & Chief Operating Officer | Nov. 19, 2025 G | 101,622 | 0 | 0 | $0 |
| Mark E Mlotek | EVP, Chief Strategic Officer | March 16, 2026 F | 98,372 | 0 | 2 | $-478,758 |
| Walter Siegel | Sr. VP & Chief Legal Officer | March 14, 2025 D | 43,191 | 0 | 0 | $0 |
| Lorelei Mcglynn | SVP, Chief Human Res. Officer | Sept. 6, 2024 S | 71,833 | 0 | 0 | $0 |
| Gerald A Benjamin | EVP, Chief Admin. Officer | May 26, 2022 S | 95,616 | 0 | 0 | $0 |
| David Mckinley | CCO&Pres. Corp. Com. Dev. Grp. | Nov. 30, 2018 S | 68,012 | 0 | 0 | $0 |
| Paul Rose | SVP, Global Supply Chain | Sept. 6, 2017 S | 17,841 | 0 | 0 | $0 |
| Robert Minowitz | Pres., Int'l Dental Group EMEA | May 12, 2017 S | 22,943 | 0 | 0 | $0 |
| Michael Racioppi | SVP Chief Merchandising Offic. | March 20, 2017 M | 23,088 | 0 | 0 | $0 |
| Peter M. Mccarthy | Pres., Global Animal Health | March 13, 2017 S | 14,277 | 0 | 0 | $0 |
| James A. Harding | SVP, Chief Technology Officer | March 8, 2017 S | 16,589 | 0 | 0 | $0 |
| Stanley Komaroff | Senior Advisor | March 2, 2016 F | 25,144 | 0 | 0 | $0 |
| Leonard A David | SVP, Chief Compliance Officer | March 17, 2015 S | 12,343 | 0 | 0 | $0 |
| William K Daniel | Director | June 12, 2026 A | 7,641 | 1 | 0 | $691,900 |
| Bradley T Sheares | Director | March 6, 2026 A | 47,623 | 0 | 0 | $0 |
| Philip A Laskawy | Director | March 6, 2026 A | 24,538 | 0 | 1 | $-228,544 |
| Reed Vaughn Tuckson | Director | June 11, 2025 F | 9,943 | 0 | 0 | $0 |
| Carol Raphael | Director | May 21, 2025 F | 33,538 | 0 | 0 | $0 |
| Anne H. Margulies | Director | March 5, 2025 F | 20,576 | 0 | 0 | $0 |
| Scott Philip Serota | Director | March 4, 2025 A | 8,213 | 0 | 0 | $0 |
| Carole T Faig | Director | March 4, 2025 A | 5,448 | 0 | 0 | $0 |
| Mohamad Ali | Director | March 4, 2025 A | 12,498 | 0 | 0 | $0 |
| Robert J. Hombach | Director | March 4, 2025 A | 2,844 | 0 | 0 | $0 |
| Steven Paladino | Director | March 4, 2024 A | 138,272 | 0 | 0 | $0 |
| Dianne E Rekow | Director | March 16, 2022 A | 18,526 | 0 | 0 | $0 |
| Barry J Alperin | Director | March 16, 2022 A | 52,473 | 0 | 0 | $0 |
| Paul Brons | Director | March 3, 2021 F | 16,854 | 0 | 0 | $0 |
| Shira Goodman | Director | March 3, 2021 A | 5,689 | 0 | 0 | $0 |
| Lawrence S Bacow | Director | March 6, 2018 F | 10,115 | 0 | 0 | $0 |
| Donald J Kabat | Director | March 6, 2018 F | 10,874 | 0 | 0 | $0 |
| Louis W Sullivan | Director | March 31, 2016 A | 14,096 | 0 | 0 | $0 |
| Norman S Matthews | Director | March 31, 2016 A | 12,890 | 0 | 0 | $0 |
| Karyn Mashima | Director | March 10, 2014 F | 19,269 | 0 | 0 | $0 |
| Irving Shafran | Director | Nov. 20, 2003 S | 750,000 | 0 | 0 | $0 |
| HENRY SCHEIN INC | 10% owner | Feb. 7, 2019 J | 0 | 0 | 0 | $0 |
| Stanley M Bergman | — | May 26, 2026 G | 253,279 | 0 | 5 | $-7,544,687 |
| Kurt P Kuehn | — | March 10, 2026 S | 15,420 | 0 | 1 | $-224,562 |
| Deborah Derby | — | March 6, 2026 A | 15,093 | 0 | 0 | $0 |
| Joseph L Herring | — | March 6, 2026 A | 30,325 | 0 | 0 | $0 |
| Margaret A Hamburg | — | May 20, 2009 M | 0 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| KKR Hawaii Holdings L.P., KKR Hawaii Holdings GP LLC, KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 filings | March 10, 2026 | 16.40% | Amendment | — | SEC |
| KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 filings | Aug. 8, 2025 | 13.00% | Amendment | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 124 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| RSPH · Invesco Exchange-Traded Fund Trust | 1.69% | 150,301 SH | Aug. 8, 2026 | Daily |
| FLV · AMERICAN CENTURY ETF TRUST | 1.67% | 76,819 NS | May 31, 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1.31% | 154,050 NS | April 30, 2026 | N-PORT |
| GURU · Global X Funds | 1.05% | 8,187 NS | April 30, 2026 | N-PORT |
| TAX · EA Series Trust | 0.98% | 3,244 NS | May 29, 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0.64% | 123,268 SH | Aug. 8, 2026 | Daily |
| SMMV · iShares Trust | 0.60% | 19,668 SH | Aug. 8, 2026 | Daily |
| FBCV · FIDELITY COVINGTON TRUST | 0.35% | 7,509 NS | April 30, 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0.31% | 13,083 NS | April 30, 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.31% | 17,947 NS | April 30, 2026 | N-PORT |
| ANEW · ProShares Trust | 0.28% | 283 NS | May 31, 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0.28% | 55,872 SH | Aug. 8, 2026 | Daily |
| ISCV · iShares Trust | 0.26% | 20,602 SH | Aug. 8, 2026 | Daily |
| DEUS · DBX ETF Trust | 0.22% | 7,905 NS | May 29, 2026 | N-PORT |
| AFMC · First Trust Exchange-Traded Fund VI… | 0.22% | 4,614 NS | May 31, 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0.21% | 2,354,606 SH | Aug. 8, 2026 | Daily |
| DFVE · DoubleLine ETF Trust | 0.21% | 765 NS | March 31, 2026 | N-PORT |
| SPXD · DBX ETF Trust | 0.20% | 181 NS | May 31, 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0.20% | 16,567 NS | April 30, 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.18% | 245 NS | May 31, 2026 | N-PORT |
| ESML · iShares Trust | 0.18% | 58,273 SH | Aug. 8, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.18% | 333,590 NS | April 30, 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.18% | 55,767 NS | April 30, 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.17% | 1,416,056 SH | Aug. 8, 2026 | Daily |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.16% | 42,689 NS | April 30, 2026 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0.14% | 270,326 NS | May 31, 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0.14% | 4,118 NS | April 30, 2026 | N-PORT |
| IYH · iShares Trust | 0.14% | 58,901 SH | Aug. 8, 2026 | Daily |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.14% | 24,631 NS | April 30, 2026 | N-PORT |
| ISCB · iShares Trust | 0.13% | 4,208 SH | Aug. 8, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.13% | 48,980 NS | April 30, 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0.12% | 21,075 NS | April 30, 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.12% | 293,098 SH | Aug. 8, 2026 | Daily |
| SMMD · iShares Trust | 0.12% | 49,577 SH | Aug. 8, 2026 | Daily |
| RXL · ProShares Trust | 0.11% | 1,043 NS | May 31, 2026 | N-PORT |
| IXJ · iShares Trust | 0.11% | 51,636 SH | Aug. 8, 2026 | Daily |
| CURE · Direxion Shares ETF Trust | 0.11% | 1,994 NS | April 30, 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0.10% | 2,230,411 SH | Aug. 8, 2026 | Daily |
| IEDI · iShares U.S. ETF Trust | 0.10% | 316 SH | Aug. 8, 2026 | Daily |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.10% | 9,299 SH | Aug. 8, 2026 | Daily |
| VFMF · VANGUARD WELLINGTON FUND | 0.09% | 7,550 SH | Aug. 8, 2026 | Daily |
| IWS · iShares Trust | 0.08% | 148,171 SH | Aug. 8, 2026 | Daily |
| DFAT · Dimensional ETF Trust | 0.08% | 146,387 NS | April 30, 2026 | N-PORT |
| WSML · iShares Trust | 0.08% | 5,958 SH | Aug. 8, 2026 | Daily |
| TILT · FlexShares Trust | 0.08% | 20,790 NS | April 30, 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.07% | 82,484 SH | Aug. 8, 2026 | Daily |
| VFVA · VANGUARD WELLINGTON FUND | 0.07% | 7,214 SH | Aug. 8, 2026 | Daily |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0.07% | 6,605 NS | April 30, 2026 | N-PORT |
| IWR · iShares Trust | 0.06% | 401,448 SH | Aug. 8, 2026 | Daily |
| JSTC · Tidal Trust I | 0.06% | 2,708 NS | May 31, 2026 | N-PORT |